Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma
NCT ID: NCT01715597
Last Updated: 2017-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
50 participants
INTERVENTIONAL
2012-12-31
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ascorbic acid
ascorbic acid 2g in normal saline 500ml IV start 2hours before the operation
ascorbic acid
ascorbic acid 2g in normal saline 500ml IV start 30min before the operation and infusion for 2 hour
Normal saline
normal saline 500ml IV
Control
Normal saline 500ml IV infusion for 2hour
Normal saline
normal saline 500ml IV
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ascorbic acid
ascorbic acid 2g in normal saline 500ml IV start 30min before the operation and infusion for 2 hour
Normal saline
normal saline 500ml IV
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be planning to laparoscopic myomectomy
* images ; the number of myoma \<4
* images ; the diameter of the largest myoma \<9cm
Exclusion Criteria
* clinically significant coagulation abnormality
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kidong Kim
Assistant professor in department of OBGY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
kiding kim, M.D.
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Bundang Hospital,Gyeongg-ido,Republic of Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Gyeongg-ido, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lee B, Kim K, Cho HY, Yang EJ, Suh DH, No JH, Lee JR, Hwang JW, Do SH, Kim YB. Effect of intravenous ascorbic acid infusion on blood loss during laparoscopic myomectomy: a randomized, double-blind, placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:187-91. doi: 10.1016/j.ejogrb.2016.02.014. Epub 2016 Feb 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNUBH_GO_016
Identifier Type: -
Identifier Source: org_study_id